| dc.creator | Rodrigues, Laura Cunha | |
| dc.creator | Kerr, Ligia Regina Franco Sansigolo | |
| dc.creator | Frietas, Max Victor Carioca | |
| dc.creator | Barreto, Mauricio Lima | |
| dc.creator | Rodrigues, Laura Cunha | |
| dc.creator | Kerr, Ligia Regina Franco Sansigolo | |
| dc.creator | Frietas, Max Victor Carioca | |
| dc.creator | Barreto, Mauricio Lima | |
| dc.date.accessioned | 2022-10-07T19:01:15Z | |
| dc.date.available | 2022-10-07T19:01:15Z | |
| dc.date.issued | 2007 | |
| dc.identifier | 0264-410X | |
| dc.identifier | http://repositorio.ufba.br/ri/handle/ri/14356 | |
| dc.identifier | v. 25, n. 39-40 | |
| dc.identifier.uri | http://repositorioslatinoamericanos.uchile.cl/handle/2250/4012784 | |
| dc.description.abstract | Background: BCG vaccine protects against leprosy.
Objectives: Estimate BCG protection against leprosy by age by age.
Methods: A case control study with 226 cases of leprosy and 857 controls. BCG vaccination was ascertained via examination of BCG scars. Protection is presented for three age groups.
Results: BCG protection against leprosy was 86% (95% CI: 77–92%) in the age group 18–29; 54% (95% CI: −37% to 85%) in the age group 30–39 and 32% (95% CI: −3% to 56%) in those aged 40 or more.
Conclusions: BCG efficacy against leprosy may well last for three decades and possibly even longer. BCG vaccination must have contributed to worldwide reduction in leprosy incidence. | |
| dc.language | en | |
| dc.rights | Acesso Aberto | |
| dc.source | http://dx.doi.org/10.1016/j.vaccine.2007.07.032 | |
| dc.subject | BCG vaccine | |
| dc.subject | Leprosy | |
| dc.subject | Waning of protection | |
| dc.subject | Duration of protection | |
| dc.subject | Vaccine efficacy | |
| dc.title | Long lasting BCG protection against leprosy | |
| dc.type | Artigo de Periódico | |
